Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

MicroRNA and methylation are important epigenetic mechanisms in the pathogenesis of cancer. The role of a group of microRNA hypermethylated genes in the pathogenesis of ovarian cancer was studied and their diagnostic and prognostic potential was evaluated. Studies on a representative sample of 54 ovarian cancer specimens with the use of methyl-specific PCR resulted in detection of five microRNA genes (MIR-9-1, MIR-9-3, MIR-107, MIR-1258, and MIR-130b) methylated in the majority of tumor specimens in comparison with paired specimens of histologically intact tissue (37-57% vs. 4-9%, p<0.01). Methylation of three genes (MIR-9-1, MIR-9-3, and MIR-130b) was significantly (p≤0.05) associated with the parameters of ovarian cancer progress (clinical stage, differentiation degree, tumor size, and presence of metastases). These findings attest to oncosuppressive role of the studied microRNA genes (MIR-9-1, MIR-9-3, MIR-107, MIR-1258, and MIR-130b) in the pathogenesis and progress of ovarian cancer and indicated their prognostic potential.

Авторлар туралы

E. Braga

Research Institute of Pathology and Pathophysiology; Research Centre of Medical Genetics

Хат алмасуға жауапты Автор.
Email: eleonora10_45@mail.ru
Ресей, Moscow; Moscow

V. Loginov

Research Institute of Pathology and Pathophysiology; Research Centre of Medical Genetics

Email: eleonora10_45@mail.ru
Ресей, Moscow; Moscow

A. Burdennyi

Research Institute of Pathology and Pathophysiology

Email: eleonora10_45@mail.ru
Ресей, Moscow

E. Filippova

Research Institute of Pathology and Pathophysiology

Email: eleonora10_45@mail.ru
Ресей, Moscow

I. Pronina

Research Institute of Pathology and Pathophysiology

Email: eleonora10_45@mail.ru
Ресей, Moscow

S. Kurevlev

Research Institute of Pathology and Pathophysiology

Email: eleonora10_45@mail.ru
Ресей, Moscow

T. Kazubskaya

N. N. Blokhin Russian Cancer Research Center, the Ministry of Health of the Russian Federation

Email: eleonora10_45@mail.ru
Ресей, Moscow

D. Kushlinskii

N. N. Blokhin Russian Cancer Research Center, the Ministry of Health of the Russian Federation

Email: eleonora10_45@mail.ru
Ресей, Moscow

D. Utkin

N. N. Blokhin Russian Cancer Research Center, the Ministry of Health of the Russian Federation

Email: eleonora10_45@mail.ru
Ресей, Moscow

V. Ermilova

N. N. Blokhin Russian Cancer Research Center, the Ministry of Health of the Russian Federation

Email: eleonora10_45@mail.ru
Ресей, Moscow

N. Kushlinskii

N. N. Blokhin Russian Cancer Research Center, the Ministry of Health of the Russian Federation

Email: eleonora10_45@mail.ru
Ресей, Moscow


© Springer Science+Business Media, LLC, part of Springer Nature, 2018

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>